THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies: Table 1.
Weinblatt, M., Taylor, P., Tanaka, Y., Keystone, E., Schiff, M., Fleischmann, R., Yang, L., Arora, V., de Bono, S., Holzkaemper, T., Schlichting, D., Takeuchi, T.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.1597
Date:
June, 2016
File:
PDF, 109 KB
english, 2016